256 related articles for article (PubMed ID: 31809322)
21. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
Pokrzywinski RM; Soliman AM; Chen J; Snabes MC; Coyne KS; Surrey ES; Taylor HS
Am J Obstet Gynecol; 2020 Jun; 222(6):592.e1-592.e10. PubMed ID: 31759891
[TBL] [Abstract][Full Text] [Related]
22. Danazol for pelvic pain associated with endometriosis.
Selak V; Farquhar C; Prentice A; Singla A
Cochrane Database Syst Rev; 2007 Oct; (4):CD000068. PubMed ID: 17943735
[TBL] [Abstract][Full Text] [Related]
23. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent.
Obstet Gynecol; 2018 Dec; 132(6):e249-e258. PubMed ID: 30461694
[TBL] [Abstract][Full Text] [Related]
24. Does response to hormonal therapy predict presence or absence of endometriosis?
Jenkins TR; Liu CY; White J
J Minim Invasive Gynecol; 2008; 15(1):82-6. PubMed ID: 18262150
[TBL] [Abstract][Full Text] [Related]
25. Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms.
Bina F; Soleymani S; Toliat T; Hajimahmoodi M; Tabarrai M; Abdollahi M; Rahimi R
Pharmacol Res; 2019 Jan; 139():76-90. PubMed ID: 30412733
[TBL] [Abstract][Full Text] [Related]
26. Endometriosis: in search of optimal treatment.
Nothnick WB
Minerva Ginecol; 2010 Feb; 62(1):17-31. PubMed ID: 20186112
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.
Brown J; Crawford TJ; Allen C; Hopewell S; Prentice A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004753. PubMed ID: 28114727
[TBL] [Abstract][Full Text] [Related]
28. Use of dopamine agonists to target angiogenesis in women with endometriosis.
Pellicer N; Galliano D; Herraiz S; Bagger YZ; Arce JC; Pellicer A
Hum Reprod; 2021 Mar; 36(4):850-858. PubMed ID: 33355352
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal targets in the diagnosis and treatment of endometriosis.
Kyama CM; Mihalyi A; Simsa P; Mwenda JM; Tomassetti C; Meuleman C; D'Hooghe TM
Curr Med Chem; 2008; 15(10):1006-17. PubMed ID: 18393858
[TBL] [Abstract][Full Text] [Related]
30. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
31. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
32. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.
Allen C; Hopewell S; Prentice A; Gregory D
Cochrane Database Syst Rev; 2009 Apr; (2):CD004753. PubMed ID: 19370608
[TBL] [Abstract][Full Text] [Related]
33. Hormone treatment as first line therapy is safe and relieves pelvic pain in women with bowel endometriosis.
Andres MP; Mendes RFP; Hernandes C; Araújo SEA; Podgaec S
Einstein (Sao Paulo); 2019 May; 17(2):eAO4583. PubMed ID: 31066795
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy for endometriosis and surgical menopause.
Al Kadri H; Hassan S; Al-Fozan HM; Hajeer A
Cochrane Database Syst Rev; 2009 Jan; (1):CD005997. PubMed ID: 19160262
[TBL] [Abstract][Full Text] [Related]
36. The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
Giugliano E; Cagnazzo E; Soave I; Lo Monte G; Wenger JM; Marci R
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):209-13. PubMed ID: 23415738
[TBL] [Abstract][Full Text] [Related]
37. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?
Bayoglu Tekin Y; Guven S; Kirbas A; Kalkan Y; Tumkaya L; Guvendag Guven ES
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():1-6. PubMed ID: 25462211
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model.
Zulfikaroglu E; Kılıc S; Islimye M; Aydin M; Zergeroglu S; Batioglu S
Arch Gynecol Obstet; 2011 Apr; 283(4):799-804. PubMed ID: 20333392
[TBL] [Abstract][Full Text] [Related]
39. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
40. [Medical treatment of endometriosis: Hormonal treatment of pain, impact on evolution and future perspectives].
Geoffron S; Legendre G; Daraï E; Chabbert-Buffet N
Presse Med; 2017 Dec; 46(12 Pt 1):1199-1211. PubMed ID: 29133081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
